COOPERATIVE GROUP OUTREACH PROGRAM

合作团体外展计划

• 批准号: 3558298
• 负责人: THOMAS E DAVIS
• 金额: $ 36.62万
• 依托单位: CANCER PREVENTION INSTIT OF CALIFORNIA
• 依托单位国家: 美国
• 财政年份: 1985
• 资助国家: 美国
• 起止时间: 1985-02-01 至 1987-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3558298
• 关键词: cancer information system; cancer rehabilitation /care; community health services; continuing education; cooperative study; medical outreach /case finding; neoplasm /cancer education

The Northern California Cancer Program and its clinical research arm, the Northern California Oncology Group, through the continuation of the Cooperative Group Outreach program, plan to foster state-of-the-art cancer management for all patients treated in the communities by providing the opportunity for community health care teams to participate in cancer treatment protocols. Support to the new and established Outreach communities will be provided; at the same tiem, incentives will be available to enhance protocol accrual and participation. Developing communities will have access to heightened educational opportunities for physicians and a higher quality of care for patients. The Northern California Cancer Program will provide assistance to all communities in meeting responsibilities for the protection of human subjects. The coordinated network of community hospitals and physicians developed by this program will serve as a resource for the implementation of other appropriate cancer control research activities and for the National Cancer Institute evaluation programs related to the Cooperative Group Outreach Program. The Northern California Cancer program and the Northern California Oncology Group will continue to evaluate the extent to which this program performs its stated objectives by the analysis of such criteria as accrual, protocol compliance, data documentation through audits, and participation in all aspects of clinical research including protocol development and attendance at regularly scheduled Northern California Oncology Group meetings.

北方加州癌症项目及其临床研究部门， 北方加州肿瘤学小组，通过延续 合作小组外展计划，计划培养最先进的癌症 为所有在社区接受治疗的患者提供 社区医疗团队参与癌症治疗的机会 治疗方案。 支持新的和已设立的外联方案 将提供社区;同时，将提供激励措施， 可用于增强方案累积和参与。 发展中 社区将获得更多的教育机会， 为患者提供更高质量的护理。 北方 加州癌症计划将为所有社区提供援助， 履行保护人类受试者的责任。 的 社区医院和医生的协调网络， 该计划将作为实施其他 适当的癌症控制研究活动和国家癌症 制定与合作小组外联有关的评价方案 程序. 北方加州癌症项目和北方 加州肿瘤学小组将继续评估 该计划通过分析这些因素来实现其既定目标， 标准包括累积、方案依从性、数据记录， 审计，并参与临床研究的各个方面，包括 制定协议并出席定期安排的北方 加州肿瘤学小组会议。

项目成果

Esorubicin in refractory metastatic carcinoma of the breast: a Northern California Oncology Group Study.

Esorubicin 在难治性转移性乳腺癌中的应用：北加州肿瘤学小组研究。

• 发表时间: 1987
• 期刊: Cancer treatment reports
• 作者: Carlson,RW;Billingham,ME;Kohler,M;Johnson,FD;Doroshow,JH;Torti,FM
• 通讯作者: Torti,FM

A Multiinstitutional Evaluation of the Analgesic Efficacy and Safety of Ketorolac Tromethamine, Acetaminophen plus Codeine, and Placebo in Cancer Pain

酮咯酸氨丁三醇、对乙酰氨基酚加可待因和安慰剂治疗癌性疼痛的镇痛功效和安全性的多机构评估

• DOI: 10.1002/j.1875-9114.1990.tb02577.x
• 发表时间: 1990
• 期刊: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
• 作者: R. Carlson;R. Borrison;Harvey B. Sher;P. Eisenberg;P. Mowry;E. Wolin
• 通讯作者: E. Wolin

Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma.

高肿瘤负荷多发性骨髓瘤诱导联合化疗后半体巩固放疗。

• DOI: 10.1200/jco.1992.10.11.1769
• 发表时间: 1992
• 期刊: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
• 作者: MacKenzie,MR;Wold,H;George,C;Gandara,D;Ray,G;Schiff,S;Shields,J;Artim,R;Davidson,H;Meyers,F
• 通讯作者: Meyers,F

Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group.

曲美曲沙治疗局部晚期或转移性胰腺癌。

• DOI: 10.1007/bf00198597
• 发表时间: 1990
• 期刊: Investigational new drugs
• 影响因子: 3.4
• 作者: Carlson,RW;Doroshow,JH;Odujinrin,OO;Flam,MS;Malec,M;Lamborn,KR
• 通讯作者: Lamborn,KR

A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuri

北加州肿瘤学组对 5-氟尿嘧啶或 5-氟脱氧尿嘧啶治疗失败的晚期结直肠癌患者进行了亚叶酸加 5-氟尿嘧啶与序贯甲氨蝶呤、5-氟尿嘧啶和亚叶酸的随机试验

• 发表时间: 1987
• 期刊: NCI monographs : a publication of the National Cancer Institute
• 作者: Valone,FH;Kohler,M;Fisher,K;Hannigan,J;Flam,M;Gandara,D;Hendrickson,C;Richman,E;Yu,KP
• 通讯作者: Yu,KP